Medical Innovations Incubator GmbH - Tübingen
  • About Us
    • Our Approach
    • Team
    • Partner
    • Contact
    • Press
  • Startups
    • 4C Services
    • 4C Grant Editor
    • 4C Accelerator
    • Fundraising
    • Startup BW Pre-Seed
    • Portfolio
  • Corporates
    • Corporate Services
    • Innovation Promotion
  • References
  • Events
    • 4C Close-up
    • 4C Unplugged
    • 4C Panels
  • Blog
  • Newsletter
  • English
  • Deutsch
Select Page
Pitch Contest “4C Check-up” – Team Semanux convinces the expert jury

Pitch Contest “4C Check-up” – Team Semanux convinces the expert jury

by Lea Rebholz | Mar 15, 2024 | News

A total of nine medical startups competed against each other in the “4C Check-up” online pitch contest. The aim of the five-minute pitch was to convince the expert jury of the product idea, the business model and the team. In the end, Lukas Schmelzeisen...
Planning, approval and implementation of a clinical investigation – Experiences of the startup Skinuvita

Planning, approval and implementation of a clinical investigation – Experiences of the startup Skinuvita

by Henrike Stutzki | Feb 1, 2024 | Blogbeitrag (EN), C3

In order for medical devices and IVDs to receive a CE marking, proof of their safety and performance is required. In most cases, there is not enough clinical data available for innovative products – for example from similar products – so that it is necessary to...
MII x OSORA – Faster go-to-market and why the medical device is now at the end of the roadmap

MII x OSORA – Faster go-to-market and why the medical device is now at the end of the roadmap

by Ingo Hämmerle | Jan 9, 2024 | Case Study (EN), Startups

 Case Study | Projekt mit OSORA medical GmbH OSORA has gathered a variety of starting points for market entry in order to position the technology for bone healing simulation. Market segments exist in the areas of education and training, implant development and...
MII x Fysor – How an idea became the product “Apelvo”

MII x Fysor – How an idea became the product “Apelvo”

by Ingo Hämmerle | Oct 27, 2023 | Case Study (EN), Startups

 Case Study | Project with Fysor GmbH An innovative product idea with a pure training approach can be launched on the market as a lifestyle product. But such a business model must also take into account the requirements and opportunities of the 4Cs in order to be...
MII x sync2brain – From business model development to a certified legal manufacturer

MII x sync2brain – From business model development to a certified legal manufacturer

by Ingo Hämmerle | Oct 23, 2023 | Case Study (EN), Startups

 Case Study | Project with sync2brain GmbH Medical innovations often emerge from research and are driven by a scientific perspective. However, in order for such product ideas to actually reach patients, a market-oriented view must be developed. This was the challenge...
The 4C Alumni Gathering 2023 – Driving medical innovation together

The 4C Alumni Gathering 2023 – Driving medical innovation together

by Lea Rebholz | Oct 12, 2023 | News

A strong network, peer-to-peer learning and collaboration with established partners in the healthcare industry are important factors for the success of MedTech startups. In order to support startup projects and young companies on this level, we invite alumni of the 4C...
Seeking investment? – The relevance of the 4Cs from an investor’s perspective

Seeking investment? – The relevance of the 4Cs from an investor’s perspective

by Lea Rebholz | Sep 26, 2023 | Blogbeitrag (EN)

Questions about the 4Cs and their interrelations play a central role in the development of a plausible business model in the healthcare sector. Obviously, networked 4C knowledge is also a key advantage in fundraising. We spoke to Christian Kraft, Director M&A and...
Selective contracts as an opportunity for startups to enter the market? – Insights by Experts of BKK Linde

Selective contracts as an opportunity for startups to enter the market? – Insights by Experts of BKK Linde

by Lea Rebholz | Aug 10, 2023 | Blogbeitrag (EN), C1

74 million people in Germany, and thus almost 90 % of the population, have statutory health insurance. So when it comes to the question of how to bring a new, innovative product to market, medtech start-ups often find a quick answer in the statutory health insurers...
MII x Erbe Elektromedizin – Bringing valuable medical innovations into use despite strategy change

MII x Erbe Elektromedizin – Bringing valuable medical innovations into use despite strategy change

by Ingo Hämmerle | Jul 27, 2023 | Case Study (EN), Corporates

 Case Study | Project with Erbe Elktromedizin GmbH Highly innovative companies are often spoilt for choice: which technologies have potential and strengthen the overall strategy? Which ideas are valuable but create inefficiencies in implementation and should not be...
From an auditor’s perspective: pros & cons of eQMS

From an auditor’s perspective: pros & cons of eQMS

by Dietmar Schaffarczyk | Jul 17, 2023 | Blogbeitrag (EN), C2

As the healthcare industry continues to grow, it is essential to ensure quality and compliance with regulatory standards. Electronic Quality Management Systems (eQMS) are increasingly being used to manage and maintain quality processes in organizations. This article...
« Older Entries
Next Entries »

Recent Posts

  • QMS According to ISO 13485: From Regulatory Obligation to Strategic Success Factor
  • 4C Unplugged 2025 – Where Innovation Meets Networking
  • 4C Unplugged 2025 – Looking Forward to October 16
  • You Can’t Be What You Can’t See!
  • MII x IntegraSkin – Aligning business model with regulatory requirements

Recent Comments

    Designed by Elegant Themes | Powered by WordPress